According to regulatory filings accessed via Tofler on January 19, 2026, Amway India’s total loss increased from ₹53.38 crore in FY24 to ₹74.25 crore in FY25. The company’s revenue from operations saw a sharp decline of 10.56%, highlighting a challenging year for the direct-selling pioneer.
Financial Snapshot: FY25 vs. FY24
| Metric | FY24 | FY25 | Change (%) |
| Revenue from Operations | ₹1,283.75 Cr | ₹1,148.16 Cr | -10.56% |
| Total Income | ₹1,293.97 Cr | ₹1,174.85 Cr | -9.2% |
| Net Loss | ₹53.38 Cr | ₹74.25 Cr | +39.1% (Wider) |
| Total Expenses | ₹1,347.37 Cr | ₹1,249.10 Cr | -7.3% |
Segment-Wise Breakdown: Nutrition and Personal Care Hit
The decline in revenue was felt across all of Amway’s major product categories, signaling a cautious approach to household spending in India
- Nutrition and Wellness: The company’s largest vertical fell 10% to ₹703.58 crore.
- Personal Care: The second-largest segment saw the steepest drop, falling 13.6% to ₹189.22 crore.
- Beauty: Revenue declined 12% to ₹96.59 crore.
- Home Care: Relatively stable, dipping only 2.65% to ₹120.29 crore.
Strategic Cost Cutting
In response to the shrinking top line, Amway India significantly slashed its operating expenses:
- Advertising & Sales Promotion: Reduced by a massive 40.6% to ₹36.20 crore.
- Royalty Payments: Accrued royalty to its US-based parent (Alticor Global Holdings) fell 15.7% to ₹55.43 crore. The company clarified that no royalty was actually paid in FY25, only accrued in the books.
- Agent Commissions: Payments to sole selling agents eased marginally by 2.73% to ₹366.91 crore.
Company Outlook: “India Remains a Top Market”
Despite the financial headwind, a company spokesperson emphasized that India remains one of Amway’s top ten markets globally with aspirations to reach the top five.
“Like any organization pursuing its growth journey, Amway India has gone through challenges that impacted business, but we are progressing according to our plans,” the spokesperson stated, reinforcing the firm’s commitment to the “Viksit Bharat 2047” vision and investments in physical infrastructure and distributor capabilities.
Conclusion: Navigating Industry Turbulence
The FY25 results indicate that Amway India is prioritizing financial discipline and category realignment over raw growth. As the direct-selling industry awaits further regulatory clarity and a rebound in rural and urban discretionary demand, Amway is banking on its core “Health and Wellbeing” mission to stabilize its Indian operations in FY26.
